InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Townsend Adam J., Responsable Commercial. Insider active across 1 company, notably Apellis Pharmaceuticals, Inc.. In total, 5 reports have been recorded. History available since 21 January 2022. The latest transaction was filed on 10 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
895 shares@ US$47.120.0007% mcap40.0% of flowCommon StockSEC:0001127602-22-004823:0
800 shares@ US$38.590.0005% mcap30.0% of flowCommon StockSEC:0001127602-22-002808:0
800 shares@ US$38.590.0005% mcap100.0% of flowCommon StockSEC:0001127602-22-002808
26,051 shares0Common StockSEC:0001127602-22-002065:0
26,051 shares0Common StockSEC:0001127602-22-002065
5 of 5 declarations
About Townsend Adam J.
Adam J. Townsend serves as Chief Commercial Officer of Apellis Pharmaceuticals, Inc. In this role, he oversees the company's commercial and marketing activities, contributing to the growth of its pharmaceutical products. Apellis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development of innovative treatments. Mr. Townsend plays a crucial role in developing strategies to reach customers and increase sales.
